SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
Loading market information…
SHH · 600161.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Beijing Tiantan Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Beijing Tiantan Biological Products Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 1.62% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Beijing Tiantan Biological Products Co., Ltd.’s next earnings report is currently expected on Oct 30, 2026, with estimated earnings per share of CN¥0.15. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Beijing Tiantan Biological Products Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:56 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥1.79B-16.31% vs estimate |
| Q1 2025 | Apr 15, 2025 | CN¥0.12-29.41% vs estimate | CN¥1.32B-14.34% vs estimate |
|---|
| Q4 2024 | Mar 27, 2025 | CN¥0.25+66.67% vs estimate | CN¥1.96B+46.41% vs estimate |
|---|
| Q3 2024 | Oct 26, 2024 | CN¥0.16+23.08% vs estimate | CN¥1.23B-4.66% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
CN¥48.46-CN¥0.16 (-0.33%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.39% below the high.
HK$50.90+HK$0.25 (+0.49%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.12% below the high.
CN¥181.75+CN¥2.75 (+1.54%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 19.04% below the high.
CN¥4.73+CN¥0.03 (+0.64%)
Shanghai RAAS Blood Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.14% below the high.
CN¥12.02+CN¥0.03 (+0.25%)
Hualan Biological Engineering Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.29% below the high.
CN¥13.63-CN¥0.24 (-1.73%)
China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.84% below the high.
CN¥19.20-CN¥0.60 (-3.03%)
Shenzhen Weiguang Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.18% below the high.
